Answer
No, the safety and efficacy of ramucirumab (Cyramza) have not been established in children and adolescents under 18 years.
Sources for this answer
- Cyramza 10 mg/ml concentrate for solution for infusionEli Lilly and Company Limited · emc · SmPC §4.2 Posology and method of administration · Version 18Document updated
Sources checked